Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

WBUR

Published October 27, 2026 at 10:01 AM MDT

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.

The Latest From Boise State Public Radio

Scandalized

In each episode of Scandalized, political scientists Charlie Hunt and Jaci Kettler unpack a political scandal from American history: the story, its scandalous details, the political meaning and motivations behind the act.

Listen to the new season of Scandalized

You make stories like this possible.

The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.

Your donation today helps make our local reporting free for our entire community.

Donate